Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 404,466 | 312,745 | 281,888 | 273,384 | 286,171 |
| Cost of Goods | 101,963 | 62,127 | 46,077 | 42,171 | 47,114 |
| Gross Profit | 302,503 | 250,618 | 235,811 | 231,213 | 239,057 |
| Operating Expenses | 214,278 | 207,943 | 205,921 | 199,285 | 165,614 |
| Operating Income | 89,188 | 42,802 | 29,967 | 32,099 | 73,557 |
| Interest Expense | 8,240 | 0 | 6 | 0 | 0 |
| Other Income | 3,246 | 565 | 2,104 | -156 | -191 |
| Pre-tax Income | 84,194 | 43,367 | 32,065 | 31,943 | 73,366 |
| Income Tax | 29,928 | 13,108 | 13,922 | 15,830 | 26,182 |
| Net Income Continuous | 54,266 | 30,259 | 18,143 | 16,113 | 47,184 |
| Net Income Discontinuous | -17,525 | N/A | N/A | N/A | N/A |
| Minority Interests | N/A | -876 | -5,381 | -6,906 | -4,514 |
| Net Income | $36,741 | $31,135 | $23,524 | $23,019 | $51,698 |
| EPS Basic Total Ops | 0.98 | 0.86 | 0.65 | 0.65 | 1.63 |
| EPS Basic Continuous Ops | 1.45 | 0.84 | 0.50 | 0.45 | 1.48 |
| EPS Basic Discontinuous Ops | -0.47 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.88 | 0.85 | 0.65 | 0.64 | 1.59 |
| EPS Diluted Continuous Ops | 1.26 | 0.82 | 0.50 | 0.45 | 1.45 |
| EPS Diluted Discontinuous Ops | -0.38 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $121,641 | $61,760 | $41,164 | $41,454 | $79,547 |